Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 6, 2011, Pages 1044-1055

  Sarkey, J P ^a   Chu, M ^a   McShane, M ^a   Bovo, E ^a   Mou, Y Ait ^a   Zima, A V ^a   de Tombe, P P ^a   Kartje, G L ^a,b   Martin, J L ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

Cell death; Ischemic cardiomyopathy; Myocardial infarction; Reticulon 4A; Sarcoplasmic endoplasmic reticulum

Indexed keywords

CASPASE 3; PHOSPHATIDYLSERINE; PROTEIN NOGO A; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELLULAR DISTRIBUTION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM; GENE TRANSLOCATION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE POTENTIAL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REOXYGENATION;

ANIMALS; APOPTOSIS; CALCIUM; CARDIOMYOPATHY, DILATED; CASPASE 3; CELL HYPOXIA; CYTOCHROMES C; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MYELIN PROTEINS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PHOSPHATIDYLSERINES; RATS; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 79955671190     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.03.004     Document Type: Article

References (74)

1. Anversa P., Cheng W., Liu Y., Leri A., Redaelli G., Kajstura J. Apoptosis and myocardial infarction. Basic Res. Cardiol. 1998, 93(Suppl 3):8-12.
2. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L.M., et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2726-H2731.
3. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Exp. Observ. Clin. Implications Circ. 1990, 81:1161-1172.
4. Olivetti G., Quaini F., Sala R., Lagrasta C., Corradi D., Bonacina E., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J. Mol. Cell. Cardiol. 1996, 28:2005-2016.
5. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 1994, 94:1621-1628.
6. Hofstra L., Liem I.H., Dumont E.A., Boersma H.H., van Heerde W.L., Doevendans P.A., et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000, 356:209-212.
7. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., Voipio-Pulkki L.M. Apoptosis in human acute myocardial infarction. Circulation 1997, 95:320-323.
8. Regula K.M., Kirshenbaum L.A. Apoptosis of ventricular myocytes: a means to an end. J. Mol. Cell. Cardiol. 2005, 38:3-13.
9. Webster K.A. Programmed death as a therapeutic target to reduce myocardial infarction. Trends Pharmacol. Sci. 2007, 28:492-499.
10. Lee Y., Gustafsson A.B. Role of apoptosis in cardiovascular disease. Apoptosis 2009, 14:536-548.
11. Tanaka M., Ito H., Adachi S., Akimoto H., Nishikawa T., Kasajima T., et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 1994, 75:426-433.
12. Lee P., Sata M., Lefer D.J., Factor S.M., Walsh K., Kitsis R.N. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H456-H463.
13. Azfer A., Niu J., Rogers L.M., Adamski F.M., Kolattukudy P.E. Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1411-H1420.
14. Szegezdi E., Duffy A., O'Mahoney M.E., Logue S.E., Mylotte L.A., O'Brien T., et al. ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem. Biophys. Res. Commun. 2006, 349:1406-1411.
15. Thuerauf D.J., Marcinko M., Gude N., Rubio M., Sussman M.A., Glembotski C.C. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ. Res. 2006, 99:275-282.
16. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
17. Ferrari R., Ceconi C., Curello S., Cargnoni A., De Giuli F., Visioli O. Occurrence of oxidative stress during myocardial reperfusion. Mol. Cell. Biochem. 1992, 111:61-69.
18. Zamzami N., Marchetti P., Castedo M., Hirsch T., Susin S.A., Masse B., et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 1996, 384:53-57.
19. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
20. Tsujimoto Y., Nakagawa T., Shimizu S. Mitochondrial membrane permeability transition and cell death. Biochim. Biophys. Acta 2006, 1757:1297-1300.
21. Oertle T., Schwab M.E. Nogo and its paRTNers. Trends Cell Biol. 2003, 13:187-194.
22. Huber A.B., Weinmann O., Brosamle C., Oertle T., Schwab M.E. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 2002, 22:3553-3567.
23. Oertle T., van der Haar M.E., Bandtlow C.E., Robeva A., Burfeind P., Buss A., et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 2003, 23:5393-5406.
24. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000, 403:439-444.
25. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., et al. Inhibitor of neurite outgrowth in humans. Nature 2000, 403:383-384.
26. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
27. Brosamle C., Huber A.B., Fiedler M., Skerra A., Schwab M.E. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J. Neurosci. 2000, 20:8061-8068.
28. Merkler D., Metz G.A., Raineteau O., Dietz V., Schwab M.E., Fouad K. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J. Neurosci. 2001, 21:3665-3673.
29. Markus T.M., Tsai S.Y., Bollnow M.R., Farrer R.G., O'Brien T.E., Kindler-Baumann D.R., et al. Recovery and brain reorganization after stroke in adult and aged rats. Ann. Neurol. 2005, 58:950-953.
30. Hu W.H., Hausmann O.N., Yan M.S., Walters W.M., Wong P.K., Bethea J.R. Identification and characterization of a novel Nogo-interacting mitochondrial protein (NIMP). J. Neurochem. 2002, 81:36-45.
31. Nath A.K., Krauthammer M., Li P., Davidov E., Butler L.C., Copel J., et al. Proteomic-based detection of a protein cluster dysregulated during cardiovascular development identifies biomarkers of congenital heart defects. PLoS ONE 2009, 4:e4221.
32. O'Neill P., Whalley K., Ferretti P. Nogo and Nogo-66 receptor in human and chick: implications for development and regeneration. Dev. Dyn. 2004, 231:109-121.
33. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 2002, 22:5505-5515.
34. Wang H., Yao Y., Jiang X., Chen D., Xiong Y., Mu D. Expression of Nogo-A and NgR in the developing rat brain after hypoxia-ischemia. Brain Res. 2006, 1114:212-220.
35. Hunt D., Coffin R.S., Prinjha R.K., Campbell G., Anderson P.N. Nogo-A expression in the intact and injured nervous system. Mol. Cell. Neurosci. 2003, 24:1083-1102.
36. Meier S., Brauer A.U., Heimrich B., Schwab M.E., Nitsch R., Savaskan N.E. Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J. 2003, 17:1153-1155.
37. Eslamboli A., Grundy R.I., Irving E.A. Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys. Neurosci. Lett. 2006, 408:89-93.
38. Cheatwood J.L., Emerick A.J., Schwab M.E., Kartje G.L. Nogo-A expression after focal ischemic stroke in the adult rat. Stroke 2008, 39:2091-2098.
39. Bullard T.A., Protack T.L., Aguilar F., Bagwe S., Massey H.T., Blaxall B.C. Identification of Nogo as a novel indicator of heart failure. Physiol. Genomics 2008, 32:182-189.
40. Gramolini A.O., Kislinger T., Alikhani-Koopaei R., Fong V., Thompson N.J., Isserlin R., et al. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol. Cell. Proteomics 2008, 7:519-533.
41. Martin J.L., Mestril R., Hilal-Dandan R., Brunton L.L., Dillmann W.H. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 1997, 96:4343-4348.
42. Domeier T.L., Blatter L.A., Zima A.V. Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure. J. Physiol. 2009, 587:5197-5209.
43. Pradhan A.D., Case A.M., Farrer R.G., Tsai S.Y., Cheatwood J.L., Martin J.L., et al. Dendritic spine alterations in neocortical pyramidal neurons following postnatal neuronal Nogo-A knockdown. Dev. Neurosci. 2010, 32:313-320.
44. Schlaepfer D.D., Hunter T. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol. Cell. Biol. 1996, 16:5623-5633.
45. Heusch G., Schulz R., Rahimtoola S.H. Myocardial hibernation: a delicate balance. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H984-H999.
46. Li S., Carmichael S.T. Growth-associated gene and protein expression in the region of axonal sprouting in the aged brain after stroke. Neurobiol. Dis. 2006, 23:362-373.
47. Long X., Boluyt M.O., Hipolito M.L., Lundberg M.S., Zheng J.S., O'Neill L., et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J. Clin. Invest. 1997, 99:2635-2643.
48. Gorczyca W., Bigman K., Mittelman A., Ahmed T., Gong J., Melamed M.R., et al. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993, 7:659-670.
49. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31:1-9.
50. Ngoh G.A., Hamid T., Prabhu S.D., Jones S.P. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1711-H1719.
51. Szegezdi E., Logue S.E., Gorman A.M., Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006, 7:880-885.
52. Terai K., Hiramoto Y., Masaki M., Sugiyama S., Kuroda T., Hori M., et al. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol. Cell. Biol. 2005, 25:9554-9575.
53. von Harsdorf R., Li P.F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999, 99:2934-2941.
54. Zweier J.L., Flaherty J.T., Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc. Natl Acad. Sci. U.S.A. 1987, 84:1404-1407.
55. Piper H.M., Siegmund B., Ladilov Yu V., Schluter K.D. Calcium and sodium control in hypoxic-reoxygenated cardiomyocytes. Basic Res. Cardiol. 1993, 88:471-482.
56. Acevedo L., Yu J., Erdjument-Bromage H., Miao R.Q., Kim J.E., Fulton D., et al. A new role for Nogo as a regulator of vascular remodeling. Nat. Med. 2004, 10:382-388.
57. Tagami S., Eguchi Y., Kinoshita M., Takeda M., Tsujimoto Y. A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 2000, 19:5736-5746.
58. Schroder M., Kaufman R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 2005, 74:739-789.
59. Bernales S., Papa F.R., Walter P. Intracellular signaling by the unfolded protein response. Annu. Rev. Cell Dev. Biol. 2006, 22:487-508.
60. Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990, 343:269-272.
61. Papadopoulos C.M., Tsai S.Y., Alsbiei T., O'Brien T.E., Schwab M.E., Kartje G.L. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann. Neurol. 2002, 51:433-441.
62. Seymour A.B., Andrews E.M., Tsai S.Y., Markus T.M., Bollnow M.R., Brenneman M.M., et al. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J. Cereb. Blood Flow Metab. 2005, 25:1366-1375.
63. Kilic E., ElAli A., Kilic U., Guo Z., Ugur M., Uslu U., et al. Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J. Cereb. Blood Flow Metab. 2010, 30:969-984.
64. Baines C.P. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res. Cardiol. 2009, 104:181-188.
65. Heusch G., Boengler K., Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res. Cardiol. 2010, 105:151-154.
66. Buckler K.J., Vaughan-Jones R.D. Effects of mitochondrial uncouplers on intracellular calcium, pH and membrane potential in rat carotid body type I cells. J. Physiol. 1998, 513(Pt 3):819-833.
67. Brennan J.P., Southworth R., Medina R.A., Davidson S.M., Duchen M.R., Shattock M.J. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc. Res. 2006, 72:313-321.
68. Brennan J.P., Berry R.G., Baghai M., Duchen M.R., Shattock M.J. FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation. Cardiovasc. Res. 2006, 72:322-330.
69. Lesnefsky E.J., Chen Q., Moghaddas S., Hassan M.O., Tandler B., Hoppel C.L. Blockade of electron transport during ischemia protects cardiac mitochondria. J. Biol. Chem. 2004, 279:47961-47967.
70. An J., Rhodes S.S., Jiang M.T., Bosnjak Z.J., Tian M., Stowe D.F. Anesthetic preconditioning enhances Ca2+ handling and mechanical and metabolic function elicited by Na+-Ca2+ exchange inhibition in isolated hearts. Anesthesiology 2006, 105:541-549.
71. Sedlic F., Pravdic D., Ljubkovic M., Marinovic J., Stadnicka A., Bosnjak Z.J. Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth. Analg. 2009, 109:405-411.
72. Ljubkovic M., Mio Y., Marinovic J., Stadnicka A., Warltier D.C., Bosnjak Z.J., et al. Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. Am. J. Physiol. Cell Physiol. 2007, 292:C1583-C1590.
73. Riva A., Tandler B., Loffredo F., Vazquez E., Hoppel C. Structural differences in two biochemically defined populations of cardiac mitochondria. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H868-H872.
74. Boengler K., Stahlhofen S., van de Sand A., Gres P., Ruiz-Meana M., Garcia-Dorado D., et al. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res. Cardiol. 2009, 104:141-147.